Results 11 to 20 of about 5,851 (166)
Moyamoya in Hispanics: not only in Japanese
Neurology International, 2014 Moyamoya disease was first described in 1957 as hypoplasia of the bilateral internal carotid arteries, the characteristic appearance of the associated network of abnormally dilated collateral vessels on angiography was later likened to something hazy ...
Sarmad Said +5 more
doaj +2 more sources
Neurologia Medico-ChirurgicaRecent cohort studies on hemorrhagic and asymptomatic moyamoya disease have revealed that choroidal anastomosis, a type of fragile periventricular collateral pathway (periventricular anastomosis) typical of the disease, is an independent predictor of ...
Takeshi FUNAKI +2 more
doaj +2 more sources
Annals of Clinical and Translational NeurologyObjective High‐resolution MRI enables detailed assessment of intracranial vessel wall pathology in moyamoya vasculopathy. We aimed to classify adult moyamoya vasculopathy etiologies using high‐resolution MRI and to examine subtype‐specific associations ...
Guangsong Han +8 more
doaj +2 more sources
A rare cranial disease: Prolactinoma-associated moyamoya syndrome [PDF]
Ulusal Romatoloji DergisiMoyamoya disease is a rare chronic progressive cerebrovascular disease. The etiology of moyamoya disease has not been established yet. If an underlying cause is detected, moyamoya disease is called moyamoya syndrome.
Ayberk Bayramgil +3 more
doaj +2 more sources
Journal of Korean Neurosurgical Society, 2015 Moyamoya disease (MMD) is an arteriopathy of the intracranial circulation predominantly affecting the branches of the internal carotid arteries. Heterogeneity in presentation, progression and response to therapy has prompted intense study to improve the diagnosis and prognosis of this disease.
Smith, Edward, Smith, ER
openaire +5 more sources
QJM, 2016 Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease characterized by progressive stenosis at the terminal portion of the internal carotid artery and an abnormal vascular network at the base of the brain. Although its etiology is unknown, recent genetic studies have identified RNF213 in the 17q25-ter region as an important ...
M, Tahir, U, Khan
+9 more sources
Early Post-operative CT-Angiography Imaging After EC-IC Bypass Surgery in Moyamoya Patients
Frontiers in Neurology, 2021 Objective: To evaluate the clinical value of early post-operative computed tomographic angiography (CTA) after direct extracranial-intracranial (EC-IC) bypass surgery in moyamoya patients.Methods: A retrospective analysis of all adult moyamoya patients ...
Helene Hurth +19 more
doaj +1 more source
Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease
Frontiers in Neurology, 2021 Objective: To determine if elevated rates of autoimmune disease are present in children with both Down syndrome and moyamoya disease given the high rates of autoimmune disease reported in both conditions and unknown etiology of angiopathy in this ...
Jonathan D. Santoro +17 more
doaj +1 more source
Clinical value of the systemic immune-inflammation index in moyamoya disease
Frontiers in Neurology, 2023 BackgroundMoyamoya disease (MMD) is a rare cerebrovascular disorder with unknown etiology. The underlying pathophysiological mechanism of moyamoya disease remains to be elucidated, but recent studies have increasingly highlighted that abnormal immune ...
Erheng Liu +15 more
doaj +1 more source
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2000 Moyamoya disease is a specific chronic cerebrovascular occlusive disease first reported by Japanese surgeons in 1957. The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion. It may cause ischemic attacks or cerebral
I, Fleetwood, G K, Steinberg
openaire +4 more sources